■ 学術雑誌
|
総説及び解説
|
|
1.
|
中村 努†* ,太田 正穂 ,成宮 孝祐 ,佐藤 拓也 ,大木 岳志 ,林 和彦 ,山本 雅一 ,三橋 紀夫：
【進行食道癌の治療戦略 化学放射線療法vs外科療法】 進行食道癌に対する集学的治療の戦略.
癌の臨床
54
(12)
：975-979
, 2009.2
|
|
2.
|
Kuramochi Hidekazu, Hayashi Kazuhiko, Uchida Kazumi, Nakajima Go, Hatori Takashi, Danenberg Kathleen D, Danenberg Peter V, Yamamoto Masakazu：
High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1.
Cancer chemotherapy and pharmacology
63
(1)
：85-9
, 2008.12
DOI:10.1007/s00280-008-0714-x
|
|
3.
|
Uchida Kazumi, Hayashi Kazuhiko, Kuramochi Hidekazu, Nakajima Go, Yamamoto Masakazu：
[Three cases of stomatitis caused by chemotherapy for gastrointestinal cancer that responded well to lafutidine].
Gan to kagaku ryoho. Cancer&chemotherapy
35
(8)
：1435-8
, 2008.8
|
|
4.
|
Kamikozuru Hirotaka, Kuramochi Hidekazu, Hayashi Kazuhiko, Nakajima Go, Yamamoto Masakazu：
ERCC1 codon 118 polymorphism is a useful prognostic marker in patients with pancreatic cancer treated with platinum-based chemotherapy.
International journal of oncology
32
(5)
：1091-6
, 2008.5
|
|
ページの先頭へ
|
|
